Page last updated: 2024-09-05

dabigatran and Ischemic Attack, Transient

dabigatran has been researched along with Ischemic Attack, Transient in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	32 (72.73)	24.3611
2020's	12 (27.27)	2.80

Authors

Authors	Studies
Aoyama, T; Enomoto, A; Kawano, Y; Mano, Y; Nagata, M; Nishikawa, T; Sasaki, Y; Takahashi, H	1
Alioğlu, E; Altın, C; Bilgin, N; Çetin, N; Dalgıç, O; Ekmekçi, C; Kocabaş, U; Özpelit, ME; Pekel, N; Topaloğlu, C; Tülüce, K; Tunçer, E; Türk, UÖ; Türkoğlu, Eİ; Yavuz, V; Yüksel, K	1
Ali, AK; Duffield, S; Gatto, N; Gibbs, L; Govil, P; Jaksa, A; Jonsson, P; Kent, S; Kincaid, L; Patrick, AR; Rowark, S; Sharma, M	1
Aktan, A; Arslan, B; Aslan, B; Demir, M; Ertaş, F; Günlü, S; Güzel, T; Kılıç, R; Özbek, M	1
Brinkmann, M; Diener, HC; Eschenfelder, CC; Gröschel, K; Grosse, GM; Hüsing, A; Kuklik, N; Michalski, D; Nabavi, D; Poli, S; Royl, G; Sparenberg, P; Stang, A; Weimar, C; Weissenborn, K	1
Chaturvedi, S; Mehndiratta, P	1
Atarashi, H; Fukaya, T; Inoue, H; Koretsune, Y; Okumura, K; Taniguchi, A; Uchiyama, S; Yamashita, T; Yasaka, M	1
Alrohimi, A; Buck, B; Butcher, K; Dowlatshahi, D; Kalashyan, H; Ng, K; Shamy, M; Sharma, M; Shuaib, A; Sivakumar, L; Stotts, G; Thirunavukkarasu, S	1
Brooks, MM; Glynn, NW; Hernandez, I; Saba, S; Yang, L; Zhang, Y	1
Frol, S; Hudnik, LK; Oblak, JP; Šabovič, M; Sernec, LP	1
Hocker, TLH; Neill, BC; Singh, AH; Siscos, SM	1
Böhm, M; Brueckmann, M; Connolly, S; Eikelboom, JW; Ewen, S; Ezekowitz, M; Millenaar, D; Schumacher, H; Slawik, J; Ukena, C; Wallentin, L; Yusuf, S	1
Benavente, O; Butcher, K; Coutts, SB; Field, TS; Gioia, L; Hill, MD; Ng, KH; Sharma, M	1
Alberts, MJ; Bunz, TJ; Coleman, CI; Peacock, WF	1
Collings, SL; Evans, D; Hack, G; Johnson, ME; Lefèvre, C; Maguire, A; Stynes, G	1
Braunschweig, F; Forslund, T; Hjemdahl, P; Holmström, M; Johnsson, H; von Euler, M; Wallén, H	1
Alcusky, M; Fisher, M; Goldberg, RJ; Hume, AL; Lapane, KL; McManus, DD; Tjia, J	1
Fleddermann, AM; Hayes, CH; Magalski, A; Main, ML	1
Diener, HC; Weber, R	1
Aronow, WS; Chatterjee, S; Ghosh, J; Nairooz, R; Sardar, P; Wetterslev, J	1
Gorst-Rasmussen, A; Lane, DA; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F	1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM	1
Cantürk, E; Güler, E; Karaca, O; Kızılırmak, F; Omaygenç, O	1
Cantillon, D; Coleman, CM; Kanj, M; Khalaf, S; Mould, S; Saliba, W; Wazni, O	1
Beyer-Westendorf, J; Daschkow, K; Ebertz, F; Endig, H; Förster, K; Gelbricht, V; Köhler, C; Michalski, F; Pannach, S; Sahin, K; Tittl, L; Weiss, N; Werth, S	1
Eikelboom, JW; Weitz, JI	1
Ganetsky, M	1
Lane, DA; Lee, SI; Lip, GY; Sayers, M	1
Dechering, DG; Eckardt, L; Foraita, P; Güner, F; Kochhäuser, S; Lange, PS; Leitz, P; Mönnig, G; Pott, C; Wasmer, K; Zellerhoff, S	1
Shao, XH; Wan, HB; Wang, J; Wu, S; Yang, YM; Zhang, H; Zhu, J	1
Bair, TL; Bunch, TJ; Crandall, BG; Cutler, MJ; Day, JD; Jacobs, V; Mallender, C; May, HT; Osborn, JS; Stevens, SM; Weiss, JP; Woller, SC	1
Kuwashiro, T; Okada, Y; Sahara, N	1
Buck, J; Cram, P; Gage, BF; Kaboli, P; Vaughan Sarrazin, MS	1
Horiuchi, D; Ishida, Y; Itoh, T; Kimura, M; Kinjo, T; Nishizaki, K; Okumura, K; Sasaki, K; Sasaki, S; Shoji, Y; Tomita, H; Tsushima, Y	1
Bluecher, A; Ferreirós, N; Harder, S; Labocha, S; Meyer Dos Santos, IM; Meyer Dos Santos, S; Picard-Willems, B; Singer, OC	1
Duprez, T; Eeckhoudt, S; Hermans, C; Peeters, A; Turine, G	1
Freeman, JV; Garber, AM; Go, AS; Hutton, DW; Owens, DK; Turakhia, MP; Wang, PJ; Zhu, RP	1
Connolly, SJ; Di Pasquale, G; Diener, HC; Ezekowitz, MD; Reilly, PA; Wallentin, L; Xavier, D; Yang, S; Yusuf, S	1
Bradley-Kennedy, C; Connolly, S; Kansal, AR; Linnehan, J; Peng, S; Plumb, JM; Sorensen, SV	1
Easton, JD; Johnston, SC; Kamel, H; Kim, AS	1
Ansell, J; Mantha, S	1
Douketis, JD; Gerotziafas, G; Kaatz, S; Ortel, TL; Schulman, S; Spyropoulos, AC	1
Marrone, AC; Marrone, LC	1
Aalbers, J; Hardy, G	1

Reviews

7 review(s) available for dabigatran and Ischemic Attack, Transient

Article	Year
[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs]. Lakartidningen, 2018, 10-26, Volume: 115 Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Ischemic Attack, Transient; Observational Studies as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Sweden; Thiazoles; Warfarin	2018
[New anticoagulants in patients with atrial fibrillation]. MMW Fortschritte der Medizin, 2013, May-02, Volume: 155, Issue:8 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Infarction; Dabigatran; Humans; Intracranial Embolism; Ischemic Attack, Transient; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Vitamin K	2013
Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. The American journal of cardiology, 2014, Apr-01, Volume: 113, Issue:7 Topics: Administration, Oral; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Global Health; Humans; Incidence; Ischemic Attack, Transient; Stroke; Thromboembolism	2014
Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation. The American journal of cardiology, 2016, Mar-15, Volume: 117, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Factor Xa Inhibitors; Humans; Ischemic Attack, Transient; Observational Studies as Topic; Prothrombin; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Time Factors; Treatment Outcome; Vitamin K; Warfarin	2016
[Cerebral infarction and transient ischemic attack]. Nihon rinsho. Japanese journal of clinical medicine, 2016, Volume: 74, Issue:4 Topics: Acute-Phase Reaction; Anticoagulants; Cerebral Infarction; Dabigatran; Endovascular Procedures; Factor Xa Inhibitors; Humans; Ischemic Attack, Transient; Japan; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Recombinant Proteins; Recurrence; Rivaroxaban; Tissue Plasminogen Activator; Warfarin	2016
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation. Thrombosis and haemostasis, 2012, Volume: 108, Issue:3 Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Heart Valve Diseases; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Morpholines; Multicenter Studies as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Vitamin K; Warfarin	2012
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:4 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Elective Surgical Procedures; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Ischemic Attack, Transient; Medical Records; Morpholines; Perioperative Period; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism	2012

Trials

2 trial(s) available for dabigatran and Ischemic Attack, Transient

Article	Year
Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II). International journal of stroke : official journal of the International Stroke Society, 2017, Volume: 12, Issue:8 Topics: Administration, Oral; Antithrombins; Cerebral Hemorrhage; Dabigatran; Female; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Recurrence; Sample Size; Stroke; Treatment Outcome	2017
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. The Lancet. Neurology, 2010, Volume: 9, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinolytic Agents; Humans; International Cooperation; Ischemic Attack, Transient; Longitudinal Studies; Male; Pyridines; Stroke; Treatment Outcome; Warfarin	2010

Article

Year

Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II).

International journal of stroke : official journal of the International Stroke Society, 2017, Volume: 12, Issue:8

Topics: Administration, Oral; Antithrombins; Cerebral Hemorrhage; Dabigatran; Female; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Recurrence; Sample Size; Stroke; Treatment Outcome

2017

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial.

The Lancet. Neurology, 2010, Volume: 9, Issue:12

Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinolytic Agents; Humans; International Cooperation; Ischemic Attack, Transient; Longitudinal Studies; Male; Pyridines; Stroke; Treatment Outcome; Warfarin

2010

Other Studies

35 other study(ies) available for dabigatran and Ischemic Attack, Transient

Article	Year
Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:9 Topics: Administration, Oral; Administrative Claims, Healthcare; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Japan; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles	2021
Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2021, Volume: 49, Issue:8 Topics: Age Factors; Aged; Antithrombins; Atrial Fibrillation; Cause of Death; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Myocardial Infarction; Product Surveillance, Postmarketing; Prospective Studies; Registries; Sex Factors; Stroke; Thromboembolism; Turkey	2021
Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study. BMJ open, 2022, 10-17, Volume: 12, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Hemorrhage; Humans; Ischemic Attack, Transient; Myocardial Infarction; Primary Health Care; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; United Kingdom; Warfarin	2022
Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: Insight from the AFTER-2 trial. Kardiologia polska, 2023, Volume: 81, Issue:2 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Ischemic Attack, Transient; Pyridones; Rivaroxaban; Stroke; Warfarin	2023
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Ischemic Stroke; Prospective Studies; Stroke; Vitamins	2023
Early Anticoagulation for Minor Non-Cardioembolic Stroke and Transient Ischemic Attack: Too Early to Call. Stroke, 2020, Volume: 51, Issue:4 Topics: Anticoagulants; Brain Ischemia; Dabigatran; Humans; Ischemic Attack, Transient; Stroke	2020
Dabigatran for Japanese Patients with Atrial Fibrillation and Prior Stroke: A Subgroup Analysis of the J-Dabigatran Surveillance Program. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:5 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Incidence; Ischemic Attack, Transient; Japan; Male; Middle Aged; Population Surveillance; Prospective Studies; Recurrence; Risk Factors; Secondary Prevention; Stroke; Time Factors; Treatment Outcome	2020
Early Dabigatran Treatment After Transient Ischemic Attack and Minor Ischemic Stroke Does Not Result in Hemorrhagic Transformation. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:5 Topics: Aged; Aged, 80 and over; Brain Ischemia; Dabigatran; Humans; Ischemic Attack, Transient; Ischemic Stroke; Middle Aged; Prospective Studies; Stroke; Treatment Outcome; United States	2020
Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation. The American journal of cardiology, 2020, 07-01, Volume: 126 Topics: Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Medicare; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; United States; Warfarin	2020
Effectiveness and Safety of Direct Oral Anticoagulants in the Secondary Stroke Prevention of Elderly Patients: Ljubljana Registry of Secondary Stroke Prevention. Clinical drug investigation, 2020, Volume: 40, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Female; Hemorrhage; Humans; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Pyrazoles; Pyridones; Registries; Rivaroxaban; Secondary Prevention; Stroke	2020
Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery. Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Dermatologic Surgical Procedures; Female; Humans; Ischemic Attack, Transient; Male; Perioperative Care; Postoperative Hemorrhage; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban	2021
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial). The American journal of cardiology, 2021, 06-15, Volume: 149 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Body Mass Index; Coronary Disease; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Medication Adherence; Middle Aged; Polypharmacy; Proportional Hazards Models; Stroke; Warfarin	2021
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Stroke, 2017, Volume: 48, Issue:8 Topics: Adolescent; Adult; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Cerebral Hemorrhage; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Warfarin; Young Adult	2017
Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany. PloS one, 2017, Volume: 12, Issue:10 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Germany; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Primary Health Care; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K	2017
Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs & aging, 2018, Volume: 35, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Medicare; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Secondary Prevention; Skilled Nursing Facilities; Stroke; Thromboembolism; United States	2018
Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus. The American journal of cardiology, 2019, 08-01, Volume: 124, Issue:3 Topics: Adult; Aged; Blood Transfusion; Dabigatran; Echocardiography; Epistaxis; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Ventricles; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis; Ventricular Dysfunction, Left	2019
Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study. The American journal of medicine, 2014, Volume: 127, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Denmark; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Proportional Hazards Models; Registries; Secondary Prevention; Stroke; Treatment Outcome; Warfarin	2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. The American journal of gastroenterology, 2015, Volume: 110, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment	2015
Case images: warfarin-induced skin necrosis: a 'novel' solution to an old problem. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2014, Volume: 42, Issue:8 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Humans; Ischemic Attack, Transient; Male; Middle Aged; Necrosis; Skin; Skin Diseases; Thrombosis; Warfarin	2014
Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin. Pacing and clinical electrophysiology : PACE, 2015, Volume: 38, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Dabigatran; Defibrillators, Implantable; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2015
Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry. Thrombosis and haemostasis, 2015, Volume: 113, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Embolism; Female; Germany; Hemorrhage; Humans; Intention to Treat Analysis; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Registries; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome	2015
'Realworld' use of non-vitamin K antagonist oral anticoagulants (NOACs): Lessons from the Dresden NOAC Registry. Thrombosis and haemostasis, 2015, Volume: 113, Issue:6 Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Embolism; Female; Humans; Ischemic Attack, Transient; Male; Stroke	2015
Trends and Characteristics of Emergency Department Patients Prescribed Novel Oral Anticoagulants. The Journal of emergency medicine, 2015, Volume: 49, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Patient Admission; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Warfarin	2015
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic. International journal of clinical practice, 2015, Volume: 69, Issue:11 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Clinical Audit; Dabigatran; Drug Substitution; Female; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Warfarin	2015
Data on procedural handling and complications of pulmonary vein isolation using the pulmonary vein ablation catheter GOLD®. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:5 Topics: Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Databases, Factual; Electrodes, Implanted; Equipment Design; Europe; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Retrospective Studies; Rivaroxaban; Treatment Outcome	2016
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. The American journal of cardiology, 2016, Jul-15, Volume: 118, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Dementia; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin	2016
Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System. American heart journal, 2016, Volume: 179 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diabetes Mellitus; Female; Guideline Adherence; Heart Failure; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Risk Assessment; Stroke; Ticlopidine; United States; United States Department of Veterans Affairs; Warfarin	2016
Safety and efficacy of contemporary catheter ablation for atrial fibrillation patients with a history of cardioembolic stroke in the era of direct oral anticoagulants. Journal of cardiology, 2017, Volume: 70, Issue:1 Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pulmonary Veins; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin	2017
Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients. Thrombosis and haemostasis, 2017, 02-28, Volume: 117, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Automation, Laboratory; Blood Coagulation; Chromatography, High Pressure Liquid; Dabigatran; Drug Monitoring; Female; Humans; Ischemic Attack, Transient; Male; Microfluidic Analytical Techniques; Microscopy, Fluorescence; Middle Aged; Phenprocoumon; Predictive Value of Tests; Pyrazoles; Pyridones; Reproducibility of Results; Rivaroxaban; Stroke; Tandem Mass Spectrometry; Time Factors; Treatment Outcome; Whole Blood Coagulation Time	2017
Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer. Acta neurologica Belgica, 2017, Volume: 117, Issue:3 Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Brain; Dabigatran; Female; Humans; Ischemic Attack, Transient; Tomography, X-Ray Computed; Treatment Outcome	2017
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Annals of internal medicine, 2011, Jan-04, Volume: 154, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Markov Chains; Myocardial Infarction; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Stroke; Warfarin	2011
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective. Thrombosis and haemostasis, 2011, Volume: 105, Issue:5 Topics: Aged; Atrial Fibrillation; Benzimidazoles; Canada; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Dabigatran; Embolism, Air; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Markov Chains; Pyridines; Quality-Adjusted Life Years; Stroke; Warfarin	2011
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke, 2012, Volume: 43, Issue:3 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Cost-Benefit Analysis; Dabigatran; Databases, Factual; Dose-Response Relationship, Drug; Drug Costs; Female; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Markov Chains; Models, Statistical; Monte Carlo Method; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Stroke; Warfarin	2012
Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report. Cerebrovascular diseases (Basel, Switzerland), 2012, Volume: 34, Issue:3 Topics: Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Brain; Dabigatran; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2012
Faculty of Consulting Physicians of South Africa (FCPSA): saving brain with dabigatran. Cardiovascular journal of Africa, 2012, Volume: 23, Issue:6 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Ischemic Attack, Transient; Risk Assessment; Risk Factors; Stroke; Treatment Outcome	2012